From 2,000+ patients · Ozempic vs Mounjaro is already seeing results
Ozempic vs Mounjaro: both are FDA-approved GLP-1 medications for weight loss. Ozempic (semaglutide) and Mounjaro (tirzepatide) differ in mechanism and clinical efficacy. Weight Method offers both from $199/month with virtual consultations and licensed providers.
Overview
Ozempic (semaglutide, Novo Nordisk) and Mounjaro (tirzepatide, Eli Lilly) are two separate FDA-approved, once-weekly injectable pens indicated for type 2 diabetes, made by different manufacturers and working through different mechanisms. Ozempic is a GLP-1 receptor agonist; Mounjaro is a dual GIP/GLP-1 receptor agonist. Weight Method does not dispense or prescribe either brand-name product; our program provides compounded semaglutide and compounded tirzepatide through licensed providers and U.S.-licensed pharmacies. Which medication is appropriate for you is a decision made by a licensed provider based on your individual medical profile.
Key Fact
Ozempic (semaglutide) is a GLP-1 receptor agonist; Mounjaro (tirzepatide) is a dual GIP/GLP-1 receptor agonist. They are separate FDA-approved branded products for type 2 diabetes from different manufacturers — and both are different from Weight Method's compounded program.
Source: FDA prescribing information (Ozempic; Mounjaro)
Ozempic
Mounjaro
| Ozempic | Mounjaro | |
|---|---|---|
| Manufacturer | Novo Nordisk | Eli Lilly |
| Active Ingredient | semaglutide | tirzepatide |
| FDA Indication | Type 2 diabetes | Type 2 diabetes |
| FDA Approval | 2017 | 2022 |
| Formulation | Injectable pen | Injectable pen |
| Frequency | Once weekly | Once weekly |
| Available Doses | 0.25mg, 0.5mg, 1mg, 2mg | 2.5mg, 5mg, 7.5mg, 10mg, 12.5mg, 15mg |
| Avg. Weight Loss | 10-15% | 15-21% |
| Our Price | $199/mo | $329/mo |
Key Differences
Ozempic and Mounjaro are different molecules from different manufacturers, each FDA-approved for type 2 diabetes. Ozempic acts on the GLP-1 receptor; Mounjaro acts on both the GIP and GLP-1 receptors. Which mechanism and medication is clinically appropriate for any individual depends on that person's medical history and is determined by a licensed provider, not by a general comparison. Through Weight Method, the compounded semaglutide program is $154/mo and the compounded tirzepatide program is $329/mo, each a flat all-inclusive monthly rate. The two have similar gastrointestinal side effect profiles.
Verdict
Ozempic and Mounjaro are distinct FDA-approved branded products from different manufacturers with different mechanisms; neither is what Weight Method dispenses. The right option for an individual depends on that person's medical profile and is determined by a licensed provider. Through Weight Method, compounded semaglutide is $154/mo and compounded tirzepatide is $329/mo, with provider guidance on what fits your needs.
Your Treatment Options
Compounded GLP-1 medications dispensed by U.S.-licensed 503A pharmacies.
